Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...

Biocon’s subsidiary Biocon Pharma has received the Food and Drug Administration’s permission for norepinephrine bitartrate injection (4 mg/4 ml, 1 mg/ml) in a single-dose vial, the company said in a ...

Noradrenaline (NA) is an important monoamine neurotransmitter in the nervous system. The noradrenaline transporter (NET) located on the presynaptic membrane can transport NA into presynaptic neurons.

Otsuka’s ADHD drug centanafadine is currently under review by the US FDA, with a PDUFA date of 24 July 2026.

Dr. Vimal Mehta is CEO and Co-Founder of BioXcel Therapeutics, Inc. He has over two decades of experience in the pharma and biotech industry. He also has been Senior Vice President of Business ...

Long Grove Pharmaceuticals announced the strategic in-licensing of norepinephrine in 0.9% sodium chloride premix formulation from Nevakar Injectables. This manufactured, ready-to-use formulation is ...

(RTTNews) - Sterile medication producer Baxter International Inc. (BAX) announced Thursday that the U.S. Food and Drug Administration (FDA) approval and commercial launch of premix Norepinephrine ...

Septic shock patients treated at a hospital with an insufficient supply of the drug norepinephrine were more likely to die than those treated at a hospital not experiencing the effects of the 2011 ...